CASP9 and colon carcinoma: In consideration that Src enhanced caspase-9 activity, and dasatinib blocked 5-Fu-triggered activation of Src, we then assessed whether a combination of dasatinib and 5-Fu could influence apoptosis in colon carcinoma cells.